Price T Rowe Associates Inc Nektar Therapeutics Transaction History

Price T Rowe Associates Inc

$869 Billion
Q3 2024

A detailed history of Price T Rowe Associates Inc transactions in Nektar Therapeutics stock. As of the latest transaction made, Price T Rowe Associates Inc holds 182,037 shares of NKTR stock, worth $194,779. This represents 0.0% of its overall portfolio holdings.

Number of Shares

182,037

Previous 182,037 -0.0%

Holding current value

$194,779

Previous $226,000 4.87%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$0.9 - $1.83 $51,558 - $104,835	57,287 Added 45.92%	182,037 $226,000
Q3 2023 Nov 14, 2023	BUY	$0.51 - $1.05 $29,631 - $61,005	58,100 Added 87.17%	124,750 $75,000
Q2 2023 Aug 14, 2023	SELL	$0.53 - $1.03 $117,140 - $227,650	-221,020 Reduced 76.83%	66,650 $39,000
Q1 2023 May 15, 2023	BUY	$0.64 - $3.15 $19,069 - $93,857	29,796 Added 11.55%	287,670 $203,000
Q4 2022 Feb 14, 2023	SELL	$2.03 - $4.28 $7,618 - $16,062	-3,753 Reduced 1.43%	257,874 $583,000
Q3 2022 Nov 14, 2022	SELL	$3.04 - $5.14 $53,589 - $90,607	-17,628 Reduced 6.31%	261,627 $838,000
Q2 2022 Aug 15, 2022	BUY	$3.17 - $6.17 $555,621 - $1.08 Million	175,275 Added 168.57%	279,255 $1.06 Million
Q1 2022 May 16, 2022	BUY	$4.16 - $13.72 $41,720 - $137,597	10,029 Added 10.67%	103,980 $560,000
Q4 2021 Feb 14, 2022	SELL	$10.83 - $18.41 $354,076 - $601,896	-32,694 Reduced 25.82%	93,951 $1.27 Million
Q3 2021 Nov 15, 2021	SELL	$13.07 - $18.84 $5.06 Million - $7.3 Million	-387,320 Reduced 75.36%	126,645 $2.28 Million
Q2 2021 Aug 16, 2021	SELL	$16.52 - $20.4 $300,647 - $371,259	-18,199 Reduced 3.42%	513,965 $8.82 Million
Q1 2021 May 17, 2021	SELL	$16.56 - $25.46 $277,032 - $425,920	-16,729 Reduced 3.05%	532,164 $10.6 Million
Q4 2020 Feb 16, 2021	BUY	$15.77 - $19.03 $8.66 Million - $10.4 Million	548,893 New	548,893 $9.33 Million

Others Institutions Holding NKTR

# of Institutions

147

Shares Held

139M

Call Options Held

32.6K

Put Options Held

14.1K

View Full List

About NEKTAR THERAPEUTICS

Ticker NKTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 187,404,992
Market Cap $201M
Description
Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, re...

More about NKTR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Account

Price T Rowe Associates Inc Nektar Therapeutics Transaction History